Gut microbiota-regulated tryptophan metabolism in breast cancer: mechanisms and therapeutic perspectives
Frontiers in Oncology · 25.02.2026 · 16
DOI: 10.3389/fonc.2026.1765550 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 25.02.2026. Verfasst von Jiaxi Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Guizhou Provincial Science and Technology Department.
Abstract (Originalsprache)
Breast cancer remains the most commonly diagnosed cancer among women worldwide, and multiple studies now link its development and progression to disturbances in metabolic and immune regulation. Among these factors, the gut microbiota is increasingly recognized as a modulator of host physiology through its metabolism of dietary tryptophan (Trp). Here we focus on the current understanding of the microbial metabolism of Trp, which primarily generates bioactive metabolites through the kynurenine (Kyn) pathway and the indole pathway. These metabolites can serve as endogenous ligands, activating the aryl hydrocarbon receptor (AhR) signaling pathway. They can also promote tumor stem cell characteristics, epithelial-mesenchymal transition (EMT), and metastasis via serotonin receptors (such as HTR1B/1D, HTR2B). The activation of such pathways contributes to the remodeling of the tumor immune microenvironment, alters the functions of immune cells, and directly influences the proliferation, invasion, and metastatic behavior of breast cancer cells. By integrating findings from preclinical and clinical studies, this review organizes current evidence around the “gut microbiota-Trp metabolism-breast cancer” axis and discusses clinical implications and current limitations. Targeting this metabolic network may provide new opportunities for breast cancer prevention and therapeutic intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
- The International Education College of Zhejiang Chinese Medical University, Hangzhou, China.
- Quzhou Traditional Chinese Medicine (TCM) Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, China.
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
- Bozhou District Hospital of Traditional Chinese Medicine, Zunyi, China.
- The Affiliated Traditional Chinese Medicine Hospital of Shihezi University, Shihezi, China.
Förderung
- Natural Science Foundation of Zhejiang Province
- Guizhou Provincial Science and Technology Department
Zitieren
APA
Yan, J., Qian, L., Chen, S., Karekad, M. M. A., Wu, X., Xu, M., & Xu, X. (2026). Gut microbiota-regulated tryptophan metabolism in breast cancer: mechanisms and therapeutic perspectives. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1765550
Vancouver
Yan J, Qian L, Chen S, Karekad MMA, Wu X, Xu M, et al. Gut microbiota-regulated tryptophan metabolism in breast cancer: mechanisms and therapeutic perspectives. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1765550
BibTeX
@article{Yan2026,
author = {Yan, Jiaxi and Qian, Linfeng and Chen, Shiqi and Karekad, Maryam Mohammed Abbas and Wu, Xuanwei and Xu, Musheng and Xu, Xiaohong},
title = {Gut microbiota-regulated tryptophan metabolism in breast cancer: mechanisms and therapeutic perspectives},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1765550}
}
EUVIMED